We sell in-depth short-selling reports for any company ₿ 0.10 BTC.
Contact us today.
Short Interest Update USXTNT

XTNT Short Interest Jumps as Bearish Bets Mount

Xtant Medical Holdings (XTNT) has seen a massive increase in short interest, with positions rising from 103K to 1.8M shares.

Powered by NegativePublicRelations.com
By The Forensic Ledger Desk October 5, 20261 min read
Company
Xtant Medical Holdings, Inc.
Short % Float
1.54%
Days to Cover
1

Bearish Momentum in Xtant Medical

Healthcare firm Xtant Medical Holdings, Inc. (XTNT) has recorded a substantial increase in short interest, according to the latest FINRA settlement data. The number of shares sold short rose from 103,000 to 1.8 million, a growth rate of over 999.99%. This surge indicates that short sellers are aggressively targeting the company, likely anticipating downward pressure on the stock price.

Market Outlook

Despite the massive increase in share count, the short interest as a percentage of float remains at 1.54%. While this is not an extreme level of float saturation, the rapid change in positioning is a clear signal of institutional or professional trader interest in the short side of the trade. Investors should monitor the stock for potential volatility as these new positions are established.

Source

Signal data sourced from StockTitan. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Short Interest#XTNT#Healthcare

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets. Costs: ₿ 0.10 BTC

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog